BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25522763)

  • 21. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the aryl hydrocarbon receptor is not required for the proliferation, migration, invasion, or estrogen-dependent tumorigenesis of MCF-7 breast cancer cells.
    Spink BC; Bennett JA; Lostritto N; Cole JR; Spink DC
    Mol Carcinog; 2013 Jul; 52(7):544-54. PubMed ID: 22388733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein.
    Tiong CT; Chen C; Zhang SJ; Li J; Soshilov A; Denison MS; Lee LS; Tam VH; Wong SP; Xu HE; Yong EL
    Carcinogenesis; 2012 May; 33(5):1089-97. PubMed ID: 22345291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aryl hydrocarbon receptor-independent activation of estrogen receptor-dependent transcription by 3-methylcholanthrene.
    Shipley JM; Waxman DJ
    Toxicol Appl Pharmacol; 2006 Jun; 213(2):87-97. PubMed ID: 16257430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
    J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes.
    Wang F; Hoivik D; Pollenz R; Safe S
    Nucleic Acids Res; 1998 Jun; 26(12):3044-52. PubMed ID: 9611253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.
    DuSell CD; Nelson ER; Wittmann BM; Fretz JA; Kazmin D; Thomas RS; Pike JW; McDonnell DP
    Mol Endocrinol; 2010 Jan; 24(1):33-46. PubMed ID: 19901195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short heterodimer partner (SHP) orphan nuclear receptor inhibits the transcriptional activity of aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT).
    Klinge CM; Jernigan SC; Risinger KE; Lee JE; Tyulmenkov VV; Falkner KC; Prough RA
    Arch Biochem Biophys; 2001 Jun; 390(1):64-70. PubMed ID: 11368516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of aryl hydrocarbon receptor-mediated signaling during physiological hypoxia reveals lack of competition for the aryl hydrocarbon nuclear translocator transcription factor.
    Pollenz RS; Davarinos NA; Shearer TP
    Mol Pharmacol; 1999 Dec; 56(6):1127-37. PubMed ID: 10570039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone accelerates degradation of aryl hydrocarbon receptor (AHR) and suppresses CYP1A1 induction in placental JEG-3 cell line.
    Stejskalova L; Rulcova A; Vrzal R; Dvorak Z; Pavek P
    Toxicol Lett; 2013 Nov; 223(2):183-91. PubMed ID: 24091107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omeprazole Inhibits Pancreatic Cancer Cell Invasion through a Nongenomic Aryl Hydrocarbon Receptor Pathway.
    Jin UH; Kim SB; Safe S
    Chem Res Toxicol; 2015 May; 28(5):907-18. PubMed ID: 25826687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells.
    Caruso JA; Campana R; Wei C; Su CH; Hanks AM; Bornmann WG; Keyomarsi K
    Cell Cycle; 2014; 13(16):2587-99. PubMed ID: 25486199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of aryl hydrocarbon receptor nuclear translocator protein concentration and subcellular localization in hepatic and nonhepatic cell culture lines: development of quantitative Western blotting protocols for calculation of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein in total cell lysates.
    Holmes JL; Pollenz RS
    Mol Pharmacol; 1997 Aug; 52(2):202-11. PubMed ID: 9271342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of ARNT splice variants with estrogen receptor-negative breast cancer, poor induction of vascular endothelial growth factor under hypoxia, and poor prognosis.
    Qin C; Wilson C; Blancher C; Taylor M; Safe S; Harris AL
    Clin Cancer Res; 2001 Apr; 7(4):818-23. PubMed ID: 11309328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome P450 1 family and cancers.
    Go RE; Hwang KA; Choi KC
    J Steroid Biochem Mol Biol; 2015 Mar; 147():24-30. PubMed ID: 25448748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen and aryl hydrocarbon responsiveness of ECC-1 endometrial cancer cells.
    Castro-Rivera E; Wormke M; Safe S
    Mol Cell Endocrinol; 1999 Apr; 150(1-2):11-21. PubMed ID: 10411295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An aryl hydrocarbon receptor agonist amplifies the mitogenic actions of estradiol in granulosa cells: evidence of involvement of the cognate receptors.
    Bussmann UA; Bussmann LE; Barañao JL
    Biol Reprod; 2006 Feb; 74(2):417-26. PubMed ID: 16237154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation.
    Hall JM; Barhoover MA; Kazmin D; McDonnell DP; Greenlee WF; Thomas RS
    Mol Endocrinol; 2010 Feb; 24(2):359-69. PubMed ID: 20032195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The aryl hydrocarbon receptor nuclear translocator-interacting protein 2 suppresses the estrogen receptor signaling via an Arnt-dependent mechanism.
    Li Y; Li Y; Zhang T; Chan WK
    Arch Biochem Biophys; 2010 Oct; 502(2):121-9. PubMed ID: 20674540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.